UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to NOVANTA INC. (Exact name of registrant as specified in its charter) New Brunswick, Canada 98-0110412 (State or other jurisdiction of incorporation or organization) (I. ...

Financial Data and Key Metrics Changes - Novanta reported $219 million in revenue for Q1 2023, reflecting a 7% year-over-year growth on a reported basis and 8% on an organic basis [7] - Adjusted EBITDA was $47 million, with an adjusted diluted earnings per share of $0.74, both exceeding expectations [7][27] - Non-GAAP adjusted gross profit was $101 million, maintaining a gross margin of 46%, consistent with the previous year [27] - Cash flow for the first quarter was approximately $7 million, up 28% year-over-year [29] Business Line Data and Key Metrics Changes - Medical markets sales grew 22% year-over-year, accounting for approximately 54% of total sales [11] - Advanced industrial markets, excluding microelectronics, saw a 1% year-over-year increase, representing about 38% of total sales [12] - Microelectronics, which constituted less than 9% of sales, experienced double-digit declines year-over-year [13] - The Precision Medicine and Manufacturing segment (formerly Photonics) grew 11% year-over-year [30] - Medical Solutions segment (formerly Vision) reported a 25% year-over-year growth [33] - Robotics and Automation segment (formerly Precision Motion) experienced a 9% year-over-year decline [36] Market Data and Key Metrics Changes - North America sales increased by 26% year-over-year, while Europe sales declined by 1% [14] - Sales in China, representing about 8% of total sales, fell 34% year-over-year, primarily due to microelectronics revenue decline [14] Company Strategy and Development Direction - The company emphasizes a diversified business model focused on high-growth medical and advanced industrial markets, leveraging long-term trends in robotics, automation, and precision medicine [8] - Investments in new manufacturing facilities and R&D are aimed at supporting future growth and product launches [16][49] - The company is transitioning its reporting segments to better align with strategic focus and customer needs [22][25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving the full-year outlook, citing strong demand in medical markets and a robust backlog [19][51] - The company anticipates continued challenges in the microelectronics sector but expects to stabilize and grow in other areas [41][84] - Management highlighted the importance of new product launches and design wins for future revenue growth [66][72] Other Important Information - The vitality index for new products was in the mid-teens percentage of sales, reflecting a transition year [15] - The company is working to reduce lead times for products back to historical averages, which have improved significantly [10][78] Q&A Session Summary Question: Microelectronics business and EUV lithography - Management indicated that microelectronics exposure is around 7% to 8% of total revenue, with a shift towards EUV applications expected in the future [58] Question: Update on the Czech facility - The company is winding down lower-margin product lines at the Czech facility, which has been a margin headwind but is expected to improve as new products ramp up [60][61] Question: Opportunities related to new product launches - Management confirmed that the $50 million revenue opportunity for 2025 is based on a combination of new product launches and existing customer relationships [65][72] Question: Pricing strategy in the current environment - The company is using price increases to offset inflationary pressures while aiming to expand gross margins by 100 basis points [73][74] Question: Backlog and past due backlog - Management reported a 25% sequential reduction in past due backlog and a significant decrease in lead times, indicating improved operational efficiency [77][78]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-35083 NOVANTA INC. (Exact name of registrant as specified in its charter) New Brunswick, Canada 98-0110412 (State or other jurisdiction of in ...

Novanta Inc. (NASDAQ:NOVT) Q4 2022 Results Conference Call March 1, 2023 10:00 AM ET Company Participants Ray Nash - Corporate Finance Leader Matthijs Glastra - Chair and Chief Executive Officer Robert Buckley - Chief Financial Officer Conference Call Participants Lee Jagoda - CJS Securities Brian Drab - William Blair Joseph Donahue - Baird Operator Good morning. My name is Keith, and I will be your conference operator today. At this time, I would like to welcome everyone to Novanta Inc. 2022 Fourth Quarter ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-35083 NOVANTA INC. (Exact name of registrant as specified in its charter) New Brunswick, Canada 98-0110412 (State or other jurisdiction of incorpor ...

Novanta, Inc. (NASDAQ:NOVT) Q3 2022 Earnings Conference Call November 8, 2022 10:00 AM ET Company Participants Ray Nash - Corporate Finance Leader Matthijs Glastra - Chair and Chief Executive Officer Robert Buckley - Chief Financial Officer Conference Call Participants Lee Jagoda - CJS Securities Brian Drab - William Blair Andrew Buscaglia - Berenberg Robert Mason - Robert W. Baird Operator Good morning. My name is Keith, and I will be your conference operator today. At this time, I would like to welcome e ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 Or New Brunswick, Canada 98-0110412 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 125 Middlesex Turnpike, Bedford, Massachusetts, USA 01730 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including are ...

Novanta Inc. (NASDAQ:NOVT) Q2 2022 Results Earnings Conference Call August 9, 2022 10:00 AM ET Company Participants Ray Nash - Corporate Finance Leader Matthijs Glastra - Chair and Chief Executive Officer Robert Buckley - Chief Financial Officer Conference Call Participants Lee Jagoda - CJS Securities, Inc. Brian Drab - William Blair Robert Mason - Robert W. Baird Andrew Buscaglia - Berenberg Capital Markets Operator Good morning. My name is Andrea and I will be your conference operator today. At this time, ...

Novanta A Trusted Technology Partner June 2022 Safe Harbor Statement The statements in this presentation that relate to guidance, pro forma presentations, future plans, goals, business opportunities, and future events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with business and economic conditions, failure to achieve expected benefits of acquisitions, failure to comply with the Food and Drug Administration regulations, customer and/or suppl ...

Novanta Inc (NASDAQ:NOVT) Q1 2022 Earnings Conference Call May 10, 2022 10:00 AM ET Company Participants Ray Nash - Corporate Finance Leader Matthijs Glastra - CEO & Chairman of the Board Robert Buckley - CFO Conference Call Participants Lee Jagoda - CJS Securities Rob Mason - Baird Brian Drab - William Blair Andrew Buscaglia - Berenberg Operator Good morning. My name is Andrea, and I will be your conference operator today. At this time, I would like to welcome everyone to the Novanta Inc. 2022 First Quarte ...